Abeona Sets $3.1m Price For Rare Skin Disorder Gene Therapy

Gene therapy
Abeona gets FDA approval of its rare skin disorder gene therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Gene Therapies

More from Market Access